Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease lung cancer
Symptom |brain metastases
Sentences 91
PubMedID- 26199015 Introduction: the prognostic value of egfr mutation in lung cancer patients with brain metastases is uncertain and therapeutic efficacy with egfr tki is limited.
PubMedID- 26315660 brain metastases develop in one-third of patients with non-small-cell lung cancer and are associated with a dismal prognosis, irrespective of surgery or chemo-radiotherapy.
PubMedID- 22118497 Background: brain metastases occur in 30-50% of non-small cell lung cancer (nsclc) patients and confer a worse prognosis and quality of life.
PubMedID- 22613339 Progress of treatments in non-small cell lung cancer with brain metastases.
PubMedID- 25646356 Conclusions: the expression of mirna-328 and mirna-378 in tumor tissues can be used to predict brain metastases in patients with non-small-cell lung cancer.
PubMedID- 19740564 Positive nuclear mgmt expression was detected more frequently in brain metastases as compared with primary lung cancers (83% versus 50%, p=0.004).
PubMedID- 24985049 Limited treatment options are available for lung cancer with brain metastases.
PubMedID- 26359696 brain metastases at presentation in patients with non-small cell lung cancer.
PubMedID- 22818215 A 69 year old lady has an extensive small cell lung cancer with newly diagnosed brain metastases.
PubMedID- 23128816 Correlation between brca1 expression and clinicopathological factors including brain metastases in patients with non-small-cell lung cancer.
PubMedID- 23392751 Chemotherapy for small cell lung cancer with brain metastases.
PubMedID- 24376956 Background and aim: long-term survival of lung cancer patients with brain metastases (bm) is very rare.
PubMedID- 23271367 Though brain metastases, especially with lung cancer, melanoma and breast cancer, are becoming a common clinical problem, limited treatment options have existed , such as gamma knife radiosurgeries , stereotactic radiosurgery or irradiation , uvc irradiation and whole brain radiotherapy .
PubMedID- 26114639 Background: the role of surgical treatment of lung cancer with brain metastases remains controversial.
PubMedID- 23129122 Background: this phase ii, open-label study evaluated the efficacy and safety of erlotinib as second-line therapy in non-small-cell lung cancer (nsclc) patients with brain metastases (bm).
PubMedID- 23065044 This study evaluated the efficacy of gks for treating brain metastases associated with small-cell lung cancer (sclc) after whole-brain radiotherapy (wbrt) as the first-line radiation therapy.
PubMedID- 26310285 Herein, we conducted a self-controlled study to evaluate the effect of wbrt on the permeability of bbb in non-small cell lung cancer (nsclc) patients with brain metastases (bm).
PubMedID- 24496139 I started looking for information 2 weeks after the definitive diagnosis of lung cancer with brain metastases had been made.
PubMedID- 25364413 The patient underwent whole-brain radiotherapy based on a tentative diagnosis of lung cancer with multiple brain metastases.
PubMedID- 23958057 High plasma fibrinogen concentration and platelet count unfavorably impact survival in non-small cell lung cancer patients with brain metastases.
PubMedID- 24256883 Survival and treatment options are limited for patients with brain metastases arising from non-small cell lung cancer (nsclc).
PubMedID- 24310312 The outcome of bifocal surgical resection in non-small cell lung cancer with synchronous brain metastases: results of a single center retrospective study.
PubMedID- 22220151 Because gefitinib is effective in treating brain metastases of lung cancer with egfr mutation 7, brain metastases may have been controlled in this case.
PubMedID- 19592127 Can upfront systemic chemotherapy replace stereotactic radiosurgery or whole brain radiotherapy in the treatment of non-small cell lung cancer patients with asymptomatic brain metastases.
PubMedID- 23189011 Sekine et al,3 evaluated the correlation between non-small cell lung cancer patients with brain metastases and epidermal growth factor receptor (egfr) mutations on molecular studies, as well as the radiological findings.
PubMedID- 25208818 The aim of this study was to explore prognostic factors for non-small cell lung cancer (nsclc) patients with brain metastases (bm) on the basis of egfr mutation status.
PubMedID- 26520640 We prospectively addressed whether egfr and kras mutations, eml4-alk, ros1 and ret rearrangements, or wild-type (wt), affects radiosurgery outcomes and overall survival (os) in non-small cell lung cancer (nsclc) patients with brain metastases (bm).
PubMedID- 24649011 Therapeutic strategy for non-small-cell lung cancer patients with brain metastases (review).
PubMedID- 25347291 Whole brain radiotherapy plus concurrent chemotherapy in non-small cell lung cancer patients with brain metastases: a meta-analysis.
PubMedID- 19962229 Short-course whole-brain radiotherapy (wbrt) for brain metastases due to small-cell lung cancer (sclc).
PubMedID- 25404274 Targeted agents have become the novel methods for the treatment of lung cancer with brain metastases beyond the whole brain radiation therapy, stereotactic radiosurgery and chemotherapy.
PubMedID- 20658721 Gamma knife radiosurgery in non small cell lung cancer patients with brain metastases: treatment results and prognostic factors.
PubMedID- 24790650 This review is focused on the evidence for therapeutic strategies in bone and brain metastases due to lung cancer.
PubMedID- 26275366 Delayed leukoencephalopathy of non-small cell lung cancer patients with brain metastases underwent whole brain radiation therapy.
PubMedID- 22335887 Although the presence of epidermal growth factor receptor (egfr) mutation and good response to gefitinib have been reported in non-small cell lung cancer (nsclc) patients with miliary brain metastases, the influence of the egfr mutations on the radiographic features remains unclear.
PubMedID- 22490154 Evaluation of gefitinib plus radiotherapy in non-small-cell lung cancer patients with brain metastases.
PubMedID- 21924038 The aim of this study is to explore prognostic factors in non-small cell lung cancer (nsclc) in patients with brain metastases diagnosed by constrast-enhanced mri after whole brain radiotherapy.
PubMedID- 22461932 Past medical history was notable for small cell lung cancer (sclc) with brain metastases.
PubMedID- 25556163 Rapid response of brain metastases to alectinib in a patient with non-small-cell lung cancer resistant to crizotinib.
PubMedID- 23133721 Multiple gamma knife radiosurgery for multiple metachronous brain metastases associated with lung cancer : survival time.
PubMedID- 22917813 This study was designed to determine if maintenance enzastaurin improved the outcome of whole brain radiotherapy (wbrt) in lung cancer (lc) patients with brain metastases (bms).

Page: 1 2